Oscar Health Aktie News

Oscar Health, Inc. (OSCR) Q1 2026 Earnings Call Transcript

Oscar Health (OSCR) delivered a standout Q1 2026, with $4.65B revenue, 52.7% YoY growth, and a 70.5% medical loss ratio. I reaffirm my Strong Buy rating and raise the 2026 price target to $30, citing robust execution and guidance reaffirmation. OSCR's SG&A leverage and technology platform drove operating efficiency, with Q1 Adjusted EBITDA at $727.1M and SG&A ratio likely below 15.8%.

Health insurer Oscar Health swung to a $679 million first quarter profit – the highest in company history – as its health plan membership jumped more than 50% and medical costs eased.

NEW YORK--(BUSINESS WIRE)--Oscar Health Announces Strong Financial Results for First Quarter 2026 And Reaffirms 2026 Guidance.

Don Lair writes about options income, dividend strategy, and the kind of boring-but-durable investing that actually funds retirement.

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. Appoints Director Siddhartha Sankaran as Independent Chair of the Board.

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (NYSE: OSCR) today launched Lucie Health Marketplace, a new all-in-one storefront that begins to change how America shops for healthcare. Lucie connects consumers and brokers to every major individual market plan and a curated menu of ancillary and supplemental products. Consumers buy cars, homes, and everyday products with transparency and choice. ...

Oscar Health (OSCR 1.26%) stock is gaining momentum as investors grow less pessimistic about the industry.